CXL has been approved in the U.S. for nearly a decade now. Dr. Lee will share the most memorable clinical lessons on CXL that has shaped his own clinical practice today, including the significance of FDA-approved CXL, how has it impacted patient quality-of-life (QoL) and reshaped clinical management, how to determine progression for treatment, can older patients progress, can patient younger than 14 be treated and his personal experience of retreating patients who continued to progress after investigational CXL treatments.

Over 1500 attended our event and we received amazing feedback!

Feedback from anonymous survey:

• Great talk, relevant to today's needs and insight to future procedures!

• Love the surgery videos!!! :)

• Thank you for the great information about keratoconus and cross linking!

• Great speaker and so knowledgeable! Bring them back for more talks!

• I thoroughly enjoyed this presentation. Very impressive speaker. Amazing that he was able to cover so much information in such a short period of time!

• Thank you. I always learn something new in your CE. Thank you to the sponsor also.

• I enjoyed this speaker and the topic. He was very knowledgeable and the information I received today can be implemented in my practice..

• Great getting info from surgeon too! Great speaker!

• I learned so much today about Keratoconus and its different ways to treat it with Dr.Lee. Expanding my knowledge on the topic to help patients understand better about keratoconus .

• Outstanding lecturer and covered all the bases. I’m a bit behind.

• It was interesting to see the advances in CXL surgery that are in the pipeline.

• Loved to hear from an MD and his surgical perspectives!

Speaker: Dr. Barry Lee

Moderator: Dr. Elise Kramer

COPE ID: 98767-TD

Category: Trt/Mngmnt Ocular Disease

This event is COPE approved for 1 hour of CE credit.

Thank you to Glaukos for providing an educational grant for this event.